right-img

Home | Equities Analysts Set Expectations for CytomX Therapeutics, Inc.’s FY2021 Earnings (CTMX)

Equities Analysts Set Expectations for CytomX Therapeutics, Inc.’s FY2021 Earnings (CTMX)

January 05, 2017
CytomX Therapeutics, Inc. (NASDAQ:CTMX) – Research analysts at Oppenheimer Holdings issued their FY2021 earnings per share (EPS) estimates for CytomX Therapeutics in a research report issued on Monday. Oppenheimer Holdings analyst L. Cann expects that the brokerage will post earnings per share of ($4.39) for the year. Oppenheimer Holdings has a “Market Perform” rating on […]
Read more at:https://www.americanbankingnews.com/2017/01/04/equities-analysts-set-expectations-for-cytomx-therapeutics-inc-s-fy2021-earnings-ctmx.html

Site Created by finaceandbankingnewsnow.com